A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates by Douglas, AD, Baldeviano, J, Jin, J, Silk, SE, Marshall, JM, Alanine, DGW, Wang, C, Edwards, NJ, Draper, SJ

Probability of transmission of malaria from mosquito to human is regulated by mosquito parasite density in naïve and vaccinated hosts by Churcher, TS, Sinden, RE, Edwards, NJ, Poulton, ID, Rampling, TW, Brock, PM, Griffin, JT, Upton, LM, Zakutansky, SE, Sala, KA, Angrisano, F, Hill, AVS, Blagborough, AM

A systematic analysis of the human immune response to Plasmodium vivax by Bach, FA, Muñoz Sandoval, D, Mazurczyk, M, Themistocleous, Y, Rawlinson, TA, Harding, AC, Kemp, A, Silk, SE, Barrett, JR, Edwards, NJ, Ivens, A, Rayner, JC, Minassian, AM, Napolitani, G, Draper, SJ, Spence, PJ

Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens by Barrett, JR, Silk, SE, Mkindi, CG, Kwiatkowska, KM, Hou, MM, Lias, AM, Kalinga, WF, Mtaka, IM, McHugh, K, Bardelli, M, Davies, H, King, LDW, Edwards, NJ, Chauhan, VS, Mukherjee, P, Rwezaula, S, Chitnis, CE, Olotu, AI, Minassian, AM, Draper, SJ, Nielsen, CM

Mapping immune variation and var gene switching in naive hosts infected with Plasmodium falciparum by Milne, K, Ivens, A, Reid, AJ, Lotkowska, ME, O'Toole, A, Sankaranarayanan, G, Munoz Sandoval, D, Nahrendorf, W, Regnault, C, Edwards, NJ, Silk, SE, Payne, RO, Minassian, AM, Venkatraman, N, Sanders, MJ, Hill, AV, Barrett, M, Berriman, M, Draper, SJ, Rowe, JA, Spence, PJ

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection by Mentzer, AJ, O'Connor, D, Bibi, S, Chelysheva, I, Clutterbuck, EA, Demissie, T, Dinesh, T, Edwards, NJ, Felle, S, Feng, S, Flaxman, AL, Karp-Tatham, E, Li, G, Liu, X, Marchevsky, N, Godfrey, L, Makinson, R, Bull, MB, Fowler, J, Alamad, B, Malinauskas, T, Chong, AY, Sanders, K, Shaw, RH, Voysey, M, Snape, MD, Pollard, AJ, Lambe, T, Knight, JC

High level efficacy in humans of a next-generation plasmodium falciparum anti-sporozoite vaccine: R21 in Matrix-M (TM) adjuvant by Venkatraman, N, Bowyer, G, Edwards, NJ, Griffiths, O, Powlson, J, Silman, D, Morter, R, Folegatti, PM, Minassian, AM, Poulton, ID, Collins, K, Brod, F, Angell-Manning, P, Berrie, E, Brendish, N, Glenn, G, Fries, L, Baum, J, Blagborough, AM, Roberts, R, Lawrie, AM, Lewis, DJ, Faust, SN, Gilbert, S, Ewer, KJ, Hill, AV

Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: safety and parasite growth dynamics by Salkeld, J, Themistocleous, Y, Barrett, JR, Mitton, CH, Rawlinson, TA, Payne, RO, Hou, MM, Khozoee, B, Edwards, NJ, Nielsen, CM, Sandoval, DM, Bach, FA, Nahrendorf, W, Ramon, RL, Baker, M, Ramos-Lopez, F, Folegatti, PM, Quinkert, D, Ellis, KJ, Poulton, ID, Lawrie, AM, Cho, J-S, Nugent, FL, Spence, PJ, Silk, SE, Draper, SJ, Minassian, AM

Safety and immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I first-in-human trial by de Graaf, H, Payne, RO, Taylor, I, Miura, K, Long, CA, Elias, SC, Zaric, M, Minassian, AM, Silk, SE, Li, L, Poulton, ID, Baker, M, Draper, SJ, Gbesemete, D, Brendish, NJ, Martins, F, Marini, A, Mekhaiel, D, Edwards, NJ, Roberts, R, Vekemans, J, Moyle, S, Faust, SN, Berrie, E, Lawrie, AM, Hill, F, Hill, AVS, Biswas, S

Evaluation of the efficacy of chad63-mva vectored vaccines expressing circumsporozoite protein and me-trap against controlled human malaria infection in malaria-naive individuals by Hodgson, SH, Ewer, KJ, Bliss, CM, Edwards, NJ, Rampling, T, Anagnostou, NA, De Barra, E, Havelock, T, Bowyer, G, Poulton, ID, De Cassan, S, Longley, R, Illingworth, JJ, Douglas, AD, Mange, PB, Collins, KA, Roberts, R, Gerry, S, Berrie, E, Moyle, S, Colloca, S, Cortese, R, Sinden, RE, Gilbert, SC, Bejon, P, Lawrie, AM, Nicosia, A, Faust, SN, Hill, AV

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-... by Rampling, T, Ewer, KJ, Bowyer, G, Bliss, CM, Edwards, NJ, Wright, D, Payne, RO, Venkatraman, N, de Barra, E, Snudden, CM, Poulton, ID, de Graaf, H, Sukhtankar, P, Roberts, R, Ivinson, K, Weltzin, R, Rajkumar, BY, Wille-Reece, U, Lee, CK, Ockenhouse, CF, Sinden, RE, Gerry, S, Lawrie, AM, Vekemans, J, Morelle, D, Lievens, M, Ballou, RW, Cooke, GS, Faust, SN, Gilbert, S, Hill, AV

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow up of two randomised controlled trials by Voysey, M, Flaxman, A, Aboagye, J, Aley, PK, Belij-Rammerstorfer, S, Bibi, S, Bittaye, M, Cappuccini, F, Charlton, S, Clutterbuck, EA, Davies, S, Dold, C, Edwards, NJ, Ewer, K, Faust, SN, Folegatti, PM, Fowler, J, Gilbride, C, Gilbert, SC, Godfrey, L, Hallis, B, Humphries, HE, Jenkin, D, Kerridge, S, Mujadidi, YF, Plested, E, Ramasamy, MN, Robinson, H, Sanders, H, Snape, MD, Song, R, Thomas, KM, Ulaszewska, M, Woods, D, Wright, D, Pollard, AJ, Lambe, T

Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection by Hou, M, Barrett, JR, Themistocleous, Y, Rawlinson, TA, Diouf, A, Martinez, FJ, Nielsen, CM, Lias, AM, King, LDW, Edwards, NJ, Greenwood, NM, Kingham, L, Poulton, I, Khozoee, B, Goh, C, Hodgson, SH, Mac lochlainn, D, Salkeld, J, Guillotte-Blisnick, M, Huon, C, Mohring, F, Reimer, JM, Chauhan, VS, Biswas, S, Lawrie, AM, Silk, SE, Minassian, AM, Draper, SJ, Mukherjee, P, Taylor, IJ, Cho, J, Nugent, FL, Long, CA, Moon, RW, Miura, K, Chitnis, CE

Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions. by Payne, RO, Silk, SE, Elias, SC, Miura, K, Diouf, A, Galaway, F, de Graaf, H, Brendish, NJ, Poulton, ID, Griffiths, OJ, Edwards, NJ, Jin, J, Labbé, GM, Alanine, DGW, Siani, L, Di Marco, S, Roberts, R, Green, N, Berrie, EE, Ishizuka, AS, Nielsen, CN, Bardelli, M, Partey, FD, Ofori, MF, Barfod, L, Wambua, J, Murungi, LM, Osier, FH, Biswas, S, McCarthy, JS, Minassian, AM, Ashfield, R, Viebig, NK, Nugent, FL, Douglas, AD, Vekemans, J, Wright, GJ, Faust, SN, Hill, AV, Long, CA, Lawrie, AM, Draper, SJ

Controlled human malaria infection with a clone of Plasmodium vivax with high quality genome assembly by Minassian, AM, Themistocleous, Y, Silk, SE, Barrett, JR, Kemp, A, Quinkert, D, Nielsen, CM, Edwards, NJ, Rawlinson, TA, Ramos Lopez, F, Roobsoong, W, Ellis, KJ, Cho, J-S, Aunin, E, Otto, TD, Reid, AJ, Bach, FA, Labbé, GM, Poulton, ID, Marini, A, Zaric, M, Mulatier, M, Lopez Ramon, R, Baker, M, Mitton, CH, Sousa, JC, Rachaphaew, N, Kumpitak, C, Maneechai, N, Suansomjit, C, Piteekan, T, Hou, MM, Khozoee, B, McHugh, K, Roberts, DJ, Lawrie, AM, Blagborough, AM, Nugent, FL, Taylor, IJ, Johnson, KJ, Spence, PJ, Sattabongkot, J, Biswas, S, Rayner, JC, Draper, SJ

Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination by Minassian, AM, Silk, SE, Barrett, JR, Nielsen, CM, Miura, K, Diouf, A, Loos, C, Fallon, JK, Michell, AR, White, MT, Edwards, NJ, Poulton, ID, Mitton, CH, Payne, RO, Marks, M, Maxwell-Scott, H, Querol-Rubiera, A, Bisnauthsing, K, Batra, R, Ogrina, T, Brendish, NJ, Themistocleous, Y, Rawlinson, TA, Ellis, KJ, Quinkert, D, Baker, M, Lopez Ramon, R, Ramos Lopez, F, Barfod, L, Folegatti, PM, Silman, D, Datoo, M, Taylor, IJ, Jin, J, Pulido, D, Douglas, AD, de Jongh, WA, Smith, R, Berrie, E, Noe, AR, Diggs, CL, Soisson, LA, Ashfield, R, Faust, SN, Goodman, AL, Lawrie, AM, Nugent, FL, Alter, G, Long, CA, Draper, SJ